封面
市场调查报告书
商品编码
1423029

2024-2032 年按动物类型(商业、伴侣)、产品类型(药品、生物製品、药用饲料添加剂、诊断)和地区分類的动物保健市场报告

Animal Health Market Report by Animal Type (Commercial, Companion), Product Type (Pharmaceuticals, Biologicals, Medicinal Feed Additives, Diagnostics), and Region 2024-2032

出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

2023年全球动物保健市场规模达378亿美元。展望未来, IMARC Group预计到2032年市场规模将达到495亿美元,2024-2032年复合年增长率(CAGR)为2.9%。宠物主人数量的增加及其对高品质兽医护理的渴望、对人畜共患疾病的认识不断提高以及众多技术进步是推动市场的主要因素。

动物健康是指家养和野生动物的健康和正常功能状态。它涵盖动物的身体、心理和行为方面,强调它们的整体健康和生活品质。确保动物健康需要采取各种措施,例如预防保健、及时接种疫苗、适当的营养和定期兽医护理。适当的动物健康管理对于动物个体的福祉以及预防和控制影响动物和人类的疾病的传播至关重要。因此,动物健康在支持永续农业、野生动物保护和社会中人与动物的连结方面发挥着至关重要的作用。

对动物性蛋白质的需求不断增长以及宠物拥有率的不断增长将刺激预测期内市场的成长。此外,人们对人畜共患病的认识不断提高,「同一个健康」方法强调了动物预防保健和疾病管理的重要性。与此一致的是,对新的和改进的动物健康解决方案的研发(R&D)的广泛投资正在对市场成长产生积极影响。除此之外,兽医领域的许多技术进步,例如提高动物健康干预措施有效性的创新诊断、药物和治疗方式,增加了对先进兽医产品的需求。此外,旨在促进动物福利和生物安全的有利政府法规和措施正在推动市场成长。除此之外,对食品安全和品质的日益关注加速了动物保健产品在畜牧生产中的采用,以确保更健康、更安全的食品供应链。此外,由于新兴经济体可支配收入的增加,宠物照护方面的消费者支出不断增加,也促进了市场的成长。

动物保健市场趋势/驱动因素:

日益关注预防保健

动物保健产业正在经历向伴侣动物和牲畜预防性保健实践的重大转变。宠物主人和牲畜生产者认识到早期发现和积极管理健康问题的重要性,以改善动物的整体福祉并降低疾病风险。定期兽医检查、疫苗接种和量身定制的健康管理计划正在变得司空见惯。这一趋势的推动因素是提高动物生活品质并尽量减少畜牧生产中疾病爆发的经济影响。因此,对预防性动物保健产品的需求不断增长,包括疫苗、杀虫剂和营养补充剂。

生物技术和製药的进步

动物保健领域正在见证生物技术和製药领域的显着进步,改变了动物疾病的诊断和治疗方式。尖端研究和创新技术促进了针对特定动物物种和条件的专门疗法、疫苗和精准医学的开发。基因编辑和细胞疗法等生物技术突破为挑战性疾病提供了有前景的解决方案。此外,製药公司正在投资研发 (R&D),为动物创造更有效、更安全的药物。这些进步改善了治疗效果,并有助于提高动物保健的整体效率。兽医专业人员现在可以提供更有针对性和个性化的治疗计划,从而为他们照顾的动物带来更好的结果并提高生活品质。

不断发展的宠物人性化和专业宠物护理

人类与宠物之间不断发展的关係导致了一种被称为宠物人性化的现象。宠物越来越被视为不可或缺的家庭成员,导致宠物照护市场的消费者行为发生重大转变。宠物主人现在愿意花更多钱购买优质、专业的宠物护理产品和服务,以确保他们心爱的伴侣过着健康、充实的生活。这一趋势刺激了对高品质宠物营养产品、个人化治疗和先进兽医护理的需求。有机宠物食品、客製化补充剂和宠物专用医疗等各种特色产品的出现正在推动动物健康市场的成长。

目录

第一章:前言

第 2 章:范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章:执行摘要

第 4 章:简介

  • 概述
  • 主要行业趋势

第 5 章:全球动物保健市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场区隔:依动物类型
  • 市场区隔:依产品类型
  • 市场区隔:按地区
  • 市场预测

第 6 章:市场区隔:依动物类型

  • 商业的
    • 市场走向
    • 市场预测
  • 伴侣
    • 市场走向
    • 市场预测

第 7 章:市场区隔:依产品类型

  • 药品
    • 市场走向
    • 市场预测
  • 生物製品
    • 市场走向
    • 市场预测
  • 药用饲料添加剂
    • 市场走向
    • 市场预测
  • 诊断
    • 市场走向
    • 市场预测

第 8 章:市场区隔:按地区

  • 北美洲
    • 市场走向
    • 市场预测
  • 欧洲
    • 市场走向
    • 市场预测
  • 亚太地区
    • 市场走向
    • 市场预测
  • 中东和非洲
    • 市场走向
    • 市场预测
  • 拉丁美洲
    • 市场走向
    • 市场预测

第 9 章:全球动物保健产业:SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 10 章:全球动物保健产业:价值链分析

第 11 章:全球动物保健产业:波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 12 章:全球动物保健产业:价格分析

  • 主要价格指标
  • 价格结构
  • 利润分析

第13章:竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Bayer
    • Elanco
    • Merck
    • Merial
    • Zoetis Inc.
    • Biogenesis Bago
    • Boehringer Ingelheim
    • Ceva Sante Animale
    • Heska
    • Neogen
    • Novartis
    • Thermo Fisher Scientific
    • Vetoquinol
    • Virbac
Product Code: SR112024A1156

Abstract

The global animal health market size reached US$ 37.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 49.5 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. The increasing number of pet owners and their desire for high-quality veterinary care, rising awareness of zoonotic diseases, and numerous technological advancements are some of the major factors propelling the market.

Animal health refers to the state of well-being and proper functioning of animals, both domestic and wild. It encompasses the physical, mental, and behavioral aspects of animals, emphasizing their overall health and quality of life. Ensuring animal health involves taking various measures, such as preventive healthcare, timely vaccinations, appropriate nutrition, and regular veterinary care. Proper management of animal health is essential for the welfare of individual animals and for preventing and controlling the spread of diseases that can impact both animal and human populations. As a result, animal health plays a crucial role in supporting sustainable agriculture, wildlife conservation, and the human-animal bond in society.

The rising demand for animal protein and the growing pet ownership rate will stimulate the growth of the market during the forecast period. Moreover, the heightening awareness of zoonotic diseases and the One Health approach have emphasized the importance of preventive care and disease management in animals. In line with this, extensive investments in research and development (R&D) of new and improved animal health solutions are positively influencing the market growth. Apart from this, numerous technological advancements in veterinary medicine, such as innovative diagnostics, pharmaceuticals, and treatment modalities that enhance the effectiveness of animal health interventions, has augmented the demand for advanced veterinary products. Additionally, favorable government regulations and initiatives aimed at promoting animal welfare and biosecurity are propelling the market growth. Besides this, the increasing focus on food safety and quality has accelerated the adoption of animal health products in livestock production to ensure healthier and safer food supply chains. Furthermore, the inflating consumer spending on pet care due to rising disposable incomes in emerging economies is contributing to the market growth.

Animal Health Market Trends/Drivers:

Increasing focus on preventive healthcare

The animal health industry is experiencing a significant shift toward preventive healthcare practices for both companion animals and livestock. Pet owners and livestock producers recognize the importance of early detection and proactive management of health issues to improve overall animal well-being and reduce the risk of diseases. Regular veterinary check-ups, vaccinations, and tailored health management plans are becoming commonplace. This trend is fueled by a desire to enhance the quality of life for animals and minimize the economic impact of disease outbreaks in livestock production. As a result, there is a growing demand for preventive animal health products, including vaccines, parasiticides, and nutritional supplements.

Advancements in biotechnology and pharmaceuticals

The animal health sector is witnessing remarkable advancements in biotechnology and pharmaceuticals, transforming the way diseases are diagnosed and treated in animals. Cutting-edge research and innovative technologies have led to the development of specialized therapies, vaccines, and precision medicine tailored to specific animal species and conditions. Biotechnological breakthroughs, such as gene editing and cell-based therapies, offer promising solutions for challenging diseases. Additionally, pharmaceutical companies are investing in research and development (R&D) to create more effective and safer medications for animals. These advancements improve treatment outcomes and contribute to the overall efficiency of animal healthcare. Veterinary professionals can now offer more targeted and personalized treatment plans, leading to better outcomes and enhanced quality of life for animals under their care.

Growing pet humanization and specialty pet care

The evolving relationship between humans and their pets has led to a phenomenon known as pet humanization. Pets are increasingly regarded as integral family members, resulting in a significant shift in consumer behavior in the pet care market. Pet owners are now willing to spend more on premium and specialized pet care products and services to ensure their beloved companions lead healthy and fulfilling lives. This trend has catalyzed the demand for high-quality pet nutrition products, personalized treatments, and advanced veterinary care. The availability of a wide range of specialty products, such as organic pet food, customized supplements, and pet-specific medical treatments is propelling the growth of the market for animal health.

Animal Health Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global animal health market report, along with forecasts at the global and regional levels from 2024-2032. Our report has categorized the market based on animal type and product type.

Breakup by Animal Type:

Commercial

Companion

Commercial holds the largest share in the market

A detailed breakup and analysis of the market based on the animal type has also been provided in the report. This includes commercial and companion. According to the report, commercial accounted for the largest market share.

The commercial segment typically includes animals, such as livestock and poultry, that are reared for commercial needs like milk and meat. Producers and farmers are increasingly focused on maintaining the health and productivity of their herds or flocks due to the rising demand for animal-derived products, including meat, dairy, and eggs. Healthy animals lead to higher yields and improved product quality, which directly impacts the profitability of commercial operations. To achieve optimal productivity, producers are investing in preventive healthcare measures, like vaccinations, parasite control, and disease management. This in turn, has augmented the demand for a wide range of animal health products, such as vaccines, pharmaceuticals, feed additives, and hygiene solutions. The rising collaboration between commercial animal producers and veterinary professionals ensures the implementation of best practices in animal health management, thus favoring the market growth.

Breakup by Product Type:

Pharmaceuticals

Biologicals

Medicinal Feed Additives

Diagnostics

Pharmaceuticals represent the most popular product type

The report has provided a detailed breakup and analysis of the market based on the product type. This includes pharmaceuticals, biologicals, medicinal feed additives, and diagnostics. According to the report, pharmaceuticals represented the largest segment.

Pharmaceuticals refer to essential medications and therapies used to address a wide range of health conditions in animals. These pharmaceutical products cater to both companion animals and livestock, helping prevent and treat diseases, manage chronic conditions, and enhance overall animal well-being. Veterinary pharmaceutical companies are investing heavily in research and development (R&D) to create innovative and effective drugs tailored to specific animal species and health needs, thereby contributing to the segment growth. Moreover, continuous advancements in pharmaceutical technologies, such as controlled-release formulations and personalized medicine, further optimizes treatment outcomes. Additionally, pharmaceutical companies are collaborating with veterinarians, animal owners, and regulatory authorities to ensure product safety, efficacy, and compliance with stringent quality standards. Furthermore, the increasing demand for animal healthcare and the growing importance of preventive medicines are propelling the market growth.

Breakup by Region:

North America

Europe

Asia Pacific

Middle East and Africa

Latin America

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America, Europe, Asia Pacific, Middle East and Africa, and Latin America. According to the report, North America accounted for the largest market share.

North America held the biggest share in the market since the region has a large population of pet owners who prioritize the health and well-being of their companion animals, which has augmented demand for veterinary products and services. Moreover, the expanding livestock industry in North America fuels the need for animal health solutions to ensure the health and productivity of the commercial animal sector. Additionally, the presence of leading pharmaceutical companies and research institutions in the region that fosters continuous innovation in animal health products, including vaccines, pharmaceuticals, and diagnostics has catalyzed the market growth. Another major contributing aspect is the introduction of supportive government regulations and initiatives promoting animal welfare and biosecurity, encouraging investments in the animal health industry, thereby propelling the market growth.

Competitive Landscape:

The market is experiencing steady growth as key players are introducing several cutting-edge innovations to address evolving challenges and enhance animal care. They are developing advanced vaccines and therapeutics targeting specific diseases prevalent in both companion animals and livestock. Additionally, novel diagnostic tools employing advanced technologies, such as DNA testing and point-of-care devices, have been introduced by manufacturers to enable faster and more accurate disease detection. Key players are also investing in telemedicine and digital health solutions, facilitating remote consultations and personalized treatment plans for pet owners. Furthermore, the integration of data analytics and artificial intelligence (AI) technologies has improved decision-making in animal health management, optimizing treatment protocols and predictive modeling. These latest innovations by leading players in the market reflect their commitment to delivering state-of-the-art solutions and driving the animal health industry toward a more efficient and compassionate approach to animal care. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain during the forecast period (2024-2032).

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Bayer

Elanco

Merck

Merial

Zoetis Inc.

Biogenesis Bago

Boehringer Ingelheim

Ceva Sante Animale

Heska

Neogen

Novartis

Thermo Fisher Scientific

Vetoquinol

Virbac

Recent Developments:

In January 2022, Zoetis Inc., a leading animal health company, announced the U.S. Food and Drug Administration (FDA) approval of a new label indication for their product, SimparicaTrio. This groundbreaking approval grants SimparicaTrio, a chewable tablet containing sarolaner, moxidectin, and pyrantel, an extended purpose for the prevention of Borrelia burgdorferi infections in dogs. The approval is a testament to the product's potent tick-killing properties, which not only protect dogs but also contribute to the prevention of tick-borne diseases.

In January 2021, Boehringer Ingelheim, a prominent player in the animal health industry, unveiled a strategic collaboration with PetMedix, a renowned biotechnology company specializing in companion animal therapeutics. This partnership aims to harness the innovative potential of PetMedix's proprietary Ky9 platform, which is designed to develop cutting-edge antibody therapeutics for companion animals. Boehringer Ingelheim's involvement in this joint venture will focus on leveraging its extensive expertise in market access, regulatory approvals, and commercialization to bring these groundbreaking therapies to the global market.

In September 2020, Ceva Sante Animale, a leading animal health company, made a groundbreaking announcement regarding a substantial expansion in its production capacity for bacterial autogenous vaccines at its manufacturing facility in France. This impressive development represents a three-fold increase in production capability, achieved through an ambitious and forward-thinking project backed by an investment of USD 8 million. The primary focus of this innovative venture is to bolster preventative animal health measures, particularly by enhancing the availability and accessibility of bacterial autogenous vaccines.

Key Questions Answered in This Report

  • 1. What was the size of the global animal health market in 2023?
  • 2. What is the expected growth rate of the global animal health market during 2024-2032?
  • 3. What are the key factors driving the global animal health market?
  • 4. What has been the impact of COVID-19 on the global animal health market?
  • 5. What is the breakup of the global animal health market based on the animal type?
  • 6. What is the breakup of the global animal health market based on the product type?
  • 7. What are the key regions in the global animal health market?
  • 8. Who are the key players/companies in the global animal health market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Animal Health Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Animal Type
  • 5.5 Market Breakup by Product Type
  • 5.6 Market Breakup by Region
  • 5.7 Market Forecast

6 Market Breakup by Animal Type

  • 6.1 Commercial
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Companion
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product Type

  • 7.1 Pharmaceuticals
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biologicals
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Medicinal Feed Additives
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Europe
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Asia Pacific
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Middle East and Africa
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Latin America
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Global Animal Health Industry: SWOT Analysis

  • 9.1 Overview
  • 9.2 Strengths
  • 9.3 Weaknesses
  • 9.4 Opportunities
  • 9.5 Threats

10 Global Animal Health Industry: Value Chain Analysis

11 Global Animal Health Industry: Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Global Animal Health Industry: Price Analysis

  • 12.1 Key Price Indicators
  • 12.2 Price Structure
  • 12.3 Margin Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Bayer
    • 13.3.2 Elanco
    • 13.3.3 Merck
    • 13.3.4 Merial
    • 13.3.5 Zoetis Inc.
    • 13.3.6 Biogenesis Bago
    • 13.3.7 Boehringer Ingelheim
    • 13.3.8 Ceva Sante Animale
    • 13.3.9 Heska
    • 13.3.10 Neogen
    • 13.3.11 Novartis
    • 13.3.12 Thermo Fisher Scientific
    • 13.3.13 Vetoquinol
    • 13.3.14 Virbac

List of Figures

  • Figure 1: Global: Animal Health Market: Major Drivers and Challenges
  • Figure 2: Global: Animal Health Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Animal Health Market: Breakup by Animal Type (in %), 2023
  • Figure 4: Global: Animal Health Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Animal Health Market: Breakup by Region (in %), 2023
  • Figure 6: Global: Animal Health Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 7: Global: Animal Health Industry: SWOT Analysis
  • Figure 8: Global: Animal Health Industry: Value Chain Analysis
  • Figure 9: Global: Animal Health Industry: Porter's Five Forces Analysis
  • Figure 10: Global: Animal Health (Commercial) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Animal Health (Commercial) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Animal Health (Companion) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Animal Health (Companion) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Animal Health (Pharmaceuticals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Animal Health (Pharmaceuticals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Animal Health (Biologicals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Animal Health (Biologicals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Animal Health (Medicinal Feed Additives) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Animal Health (Medicinal Feed Additives) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Animal Health (Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Animal Health (Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: North America: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: North America: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Europe: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Europe: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Asia Pacific: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Asia Pacific: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Middle East and Africa: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Middle East and Africa: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Latin America: Animal Health Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Latin America: Animal Health Market Forecast: Sales Value (in Million US$), 2024-2032

List of Tables

  • Table 1: Global: Animal Health Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Animal Health Market Forecast: Breakup by Animal Type (in Million US$), 2024-2032
  • Table 3: Global: Animal Health Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 4: Global: Animal Health Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Animal Health Market: Competitive Structure
  • Table 6: Global: Animal Health Market: Key Players